CORDIS
EU research results

CORDIS

English EN

ERA-Net for research programmes on rare diseases

Project information

Grant agreement ID: 36248

  • Start date

    1 June 2006

  • End date

    31 May 2010

Funded under:

FP6-COORDINATION

  • Overall budget:

    € 2 187 377

  • EU contribution

    € 2 187 377

Coordinated by:

INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE

France

Objective

There are at least 6000 to 7000 distinct rare diseases, the great majority of them being of genetic origin. Although individually rare, taken together, rare diseases affect at least 20 million of persons in Europe. They represent a major issue in health care since a large percentage of these diseases lead to a significant decrease of life expectancy, and most of them cause chronic illness with a large impact on quality of life and the health care system.
Therefore further research on rare diseases is badly needed but is hampered by lack of resources at several levels.
(1) Few scientists work on one specific disease.
(2) There are few patients scattered over a large geographic area, causing difficulties to gather cohorts required for studies.
(3) Usually existing databases and material collections are local, small, and not accessible or standardised.
(4) Diseases often have complex clinical phenotypes and require interdisciplinary approaches to treatment and interdisciplinary cooperation for research.
Due to the small number of patients affected by a specific rare disease and fragmentation of research, efforts in each individual European country are obviously limited in objectives and power. Therefore rare diseases are a prime example of a research area that could strongly profit from coordination on a transnational scale. The European research area should be enabled to realize its potential by reorganizing and combining scientific expertise, research infrastructure, well defined patient cohorts and biological material. Nine partners have thus decided to join their efforts to overcome the inherent difficulties of research on rare diseases. The general goal E-Rare is to coordinate existing programmes and to prepare joint and strategic activities to overcome some of the limitations imposed by scattered funding and fragmentation between national research programmes.

Coordinator

INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE

Address

101 Rue De Tolbiac
Paris

France

Participants (9)

DEUTSCHE ZENTRUM FÜR LUFT- UND RAUMFAHRT E.V. (GERMAN AEROSPACE CENTER)

Germany

GERMAN FEDERAL MINISTRY OF EDUCATION AND RESEARCH

Germany

FUNDACIÓN PARA LA COOPERACIÓN Y SALUD INTERNACIONAL CARLOS III

Spain

FONDS NATIONAL DE LA RECHERCHE SCIENTIFIQUE

Belgium

CHIEF SCIENTIST OFFICE, MINISTRY OF HEALTH

Israel

ISTITUTO SUPERIORE DI SANITA

Italy

THE NETHERLANDS ORGANISATION FOR HEALTH RESEARCH AND DEVELOPMENT

Netherlands

SCIENTIFIC AND TECHNICAL RESEARCH COUNCIL OF TURKEY

Turkey

AGENCE NATIONAL DE LA RECHERCHE

France

Project information

Grant agreement ID: 36248

  • Start date

    1 June 2006

  • End date

    31 May 2010

Funded under:

FP6-COORDINATION

  • Overall budget:

    € 2 187 377

  • EU contribution

    € 2 187 377

Coordinated by:

INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE

France